Screening Algorithm for BK Virus-Associated Nephropathy Using Sequential Testing of Urinary Cytology: A Probabilistic Model Analysis

American Journal of Nephrology

Volumn 42, Issue 6, 2015, Pages 410-417

  Ma, Maggie K M ^a   Leung, Anskar Y H ^a   Lo, Kin Yee ^b   Lio, Weng In ^g   Chan, Hoi Wong ^c   Wong, Ivy ^d   Hau, Anthony K C ^e   Tam, Chun Hay ^f   Wong, Andrew K M ^b   Kuok, Un I ^g   Chau, Ka Foon ^c   Fung, Samuel K S ^d   Kwan, Tsz Hoi ^e   Wong, Sunny S H ^f   Tang, Sydney C W ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b KWONG WAH HOSPITAL   (Hong Kong)

^c QUEEN ELIZABETH HOSPITAL   (Hong Kong)

^d PRINCESS MARGARET HOSPITAL   (Hong Kong)

^e TUEN MUN HOSPITAL   (Hong Kong)

^f UNITED CHRISTIAN HOSPITAL   (Hong Kong)

^g Macau Special Administrative Region   (Macao)

Author keywords

BK virus associated nephropathy; Kidney transplantation; Polymerase chain reaction; Screening; Urine cytology

Indexed keywords

ADULT; ALGORITHM; ARTICLE; BK VIRUS ASSOCIATED NEPHROPATHY; BK VIRUS INFECTION; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; GOLD STANDARD; GRAFT RECIPIENT; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; KIDNEY INFECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY (TOPIC); NONHUMAN; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE; PREVALENCE; PRIORITY JOURNAL; PROBABILITY; QUANTITATIVE ANALYSIS; SCREENING; SENSITIVITY AND SPECIFICITY; URINE CYTOLOGY; VIRUS LOAD; ADVERSE EFFECTS; BIOPSY; BK VIRUS; BLOOD; CLINICAL DECISION SUPPORT SYSTEM; CLINICAL TRIAL; FALSE POSITIVE RESULT; KIDNEY DISEASES; MASS SCREENING; MIDDLE AGED; MULTICENTER STUDY; POLYOMAVIRUS INFECTIONS; PROCEDURES; RETROSPECTIVE STUDY; RISK FACTOR; STATISTICAL MODEL; URINALYSIS; URINE;

ADULT; ALGORITHMS; BIOPSY; BK VIRUS; DECISION SUPPORT SYSTEMS, CLINICAL; FALSE POSITIVE REACTIONS; FEMALE; HUMANS; KIDNEY DISEASES; KIDNEY TRANSPLANTATION; MALE; MASS SCREENING; MIDDLE AGED; MODELS, STATISTICAL; POLYMERASE CHAIN REACTION; POLYOMAVIRUS INFECTIONS; PREDICTIVE VALUE OF TESTS; PREVALENCE; PROBABILITY; RETROSPECTIVE STUDIES; RISK FACTORS; SENSITIVITY AND SPECIFICITY; TRANSPLANT RECIPIENTS; URINALYSIS; VIRAL LOAD;

EID: 84958103582     PISSN: 02508095     EISSN: 14219670     Source Type: Journal    
DOI: 10.1159/000443514     Document Type: Article

References (21)

1. Hirsch HH: Polyomavirus BK nephropathy: a (re-)emerging complication in renal transplantation. Am J Transplant 2002;2:25-30.
2. Hirsch HH, Steiger J: Polyomavirus BK. Lancet Infect Dis 2003;3:611-623.
3. Hariharan S: BK virus nephritis after renal transplantation. Kidney Int 2006;69:655-662.
4. Kuppachi S, Thomas B, Kokko KE: BK virus in the kidney transplant patient. Am J Med Sci 2013;345:482-488.
5. KDIGO clinical practice guideline for the care of kidney transplant recipients. Am J Transplant 2009;9(suppl 3):S1-S155.
6. Hirsch HH, Randhawa P; AST Infectious Diseases Community of Practice: BK polyomavirus in solid organ transplantation. Am J Transplant 2013;13(suppl 4):179-188.
7. Laskin BL, Goebel J: Cost-efficient screening for BK virus in pediatric kidney transplantation: a single-center experience and review of the literature. Pediatr Transplant 2010;14:589-595.
8. Huang G, Chen WF, Wang CX, Fei JG, Deng SX, Qiu J, Chen LZ: Noninvasive tool for the diagnosis of polyomavirus BK-associated nephropathy in renal transplant recipients. Diagn Microbiol Infect Dis 2013;75:292-297.
9. Nickeleit V, True K, Detwiler R, Kozlowski T, Singh H: Risk assessment for polyomavirus nephropathy using urine cytology and the detection of decoy cells: cheap and efficient. Transplantation 2012;94:e42-e44; author reply e45.
10. Leung AY, Suen CK, Lie AK, Liang RH, Yuen KY, Kwong YL: Quantification of polyoma BK viruria in hemorrhagic cystitis complicating bone marrow transplantation. Blood 2001;98:1971-1978.
11. Chan GC, Leung AY, Wong AS, Chan KW, Kwong YL, Lai KN, Tang SC: Quantification of BK viral load in asymptomatic renal allograft recipients. Ren Fail 2012;34:550-554.
12. Ranzi AD, Prolla JC, Keitel E, Brackmann R, Kist R, dos Santos G, Bica CG: The role of urine cytology for 'decoy cells' as a screening tool in renal transplant recipients. Acta Cytol 2012;56:543-547.
13. Masutani K, Shapiro R, Basu A, Tan H, Wijkstrom M, Randhawa P: The Banff 2009 Working Proposal for polyomavirus nephropathy: a critical evaluation of its utility as a determinant of clinical outcome. Am J Transplant 2012;12:907-918.
14. Sonnenberg A: We only see what we already know - a modified bayes' formula to explain inherent limitations of diagnostic tests. Med Hypotheses 2004;63:759-763.
15. Efron B, Tibshirani RJ: An Introduction to the Bootstrap. New York, Chapman and Hall/CRC, 1994.
16. Myint TM, Turner RM, Craig JC, Cross NB, Kable K, Nankivell BJ, Chapman JR, Webster AC, O'Connell P, Dwyer DE, Jeoffreys N, Roger SD, Wong G: Test performance characteristics of quantitative nucleic acid testing for polyomaviruses in kidney and kidney-pancreas transplant recipients. Clin Transplant 2013;27:E571-E579.
17. Westervelt JD, Alexander BD, Costa SF, Miller SE, Howell DN, Smith SR: Detection of BK polyomavirus after kidney transplantation: a comparison of urine electron microscopy with plasma polymerase chain reaction. Clin Transplant 2013;27:E42-E48.
18. Nankivell BJ, Renthawa J, Jeoffreys N, Kable K, O'Connell PJ, Chapman JR, Wong G, Sharma RN: Clinical utility of urinary cytology to detect BK viral nephropathy. Transplantation 2015;99:1715-1722.
19. Chakera A, Dyar OJ, Hughes E, Bennett S, Hughes D, Roberts IS: Detection of polyomavirus BK reactivation after renal transplantation using an intensive decoy cell surveillance program is cost-effective. Transplantation 2011;92:1018-1023.
20. Kiberd BA: Screening to prevent polyoma virus nephropathy: a medical decision analysis. Am J Transplant 2005;5:2410-2416.
21. Smith F, Panek R, Kiberd BA: Screening to prevent polyoma virus nephropathy in kidney transplantation: a cost analysis. Am J Transplant 2009;9:2177-2179.